The increasing upregulation of OX40 has been also reported in breast carcinoma with advancing disease and poorer outcomes.15Similarly, higher OX40 and OX40L expression has been linked to later stages and worse outcomes in head and neck cancer.16, 17. This evidence concerns the gene TNFSF4 and breast carcinoma.